
NASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$73.61
−US$1.25 · -1.67%
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
前收盤價
US$73.61
−US$1.25 · -1.67%
盤中時間採用ET。市場資料可能有所延遲。
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
日內區間
目前US$73.61
52週區間
目前US$73.61
盤中時間採用ET。市場資料可能有所延遲。
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
日內區間
目前US$73.61
52週區間
目前US$73.61
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.5億 USD | 2.2億 USD | 1.93億 USD | 1.62億 USD | 1.54億 USD |
| 銷貨成本 | 7106.3萬 USD | 6896.2萬 USD | 6643.5萬 USD | 5675.5萬 USD | 5304.2萬 USD |
| 毛利 | 1.79億 USD | 1.51億 USD | 1.27億 USD | 1.05億 USD | 1.01億 USD |
| 研究與開發 | 1413.9萬 USD | 1565萬 USD | 1696.6萬 USD | 1329.4萬 USD | 1180.1萬 USD |
| 銷售、一般及管理費用 | 9648.8萬 USD | 8299.5萬 USD | 7288.6萬 USD | 6166.6萬 USD | 5315.6萬 USD |
| 營業費用 | 1.11億 USD | 9864.5萬 USD | 9033.7萬 USD | 7806.7萬 USD | 6495.7萬 USD |
| 利息收入 | 1309.4萬 USD | 494.9萬 USD | 307.7萬 USD | 98.6萬 USD | 19.7萬 USD |
| 利息支出 | 518.4萬 USD | 20.5萬 USD | — | — | 221.9萬 USD |
| 折舊和攤銷 | 1041.8萬 USD | 967萬 USD | 951.5萬 USD | 943.3萬 USD | 1107萬 USD |
| 營業利益 | 6791.2萬 USD | 5225.6萬 USD | 3671.2萬 USD | 2682.9萬 USD | 3642.5萬 USD |
| 淨利 | 5773.4萬 USD | 4403.8萬 USD | 3010.5萬 USD | 2063.6萬 USD | 2690.7萬 USD |
公司資料更新於 2026年11月22日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$97.00
上漲空間 31.78%年度分割調整後的每股現金分配。
US$0.80
2025年(完整年度)+81.8% 自從 2021
2026年(部分年度):US$1.00
US$0.44
2,021
US$0.50
2,022
US$0.56
2,023
US$0.64
2,024
US$0.80
2,025
US$1.00
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年11月19日 | US$0.25Quarterly | 2026年11月19日 | 2026年12月3日 |
股息 | 2026年8月20日 | US$0.25Quarterly | 2026年8月20日 | 2026年9月3日 |
股息 | 2026年5月21日 | US$0.25Quarterly | 2026年5月21日 | 2026年6月4日 |
股息 | 2026年3月12日 | US$0.25Quarterly | 2026年3月12日 | 2026年3月26日 |
股息 | 2025年11月20日 | US$0.20Quarterly | 2025年11月20日 | 2025年12月4日 |
股息 | 2025年8月21日 | US$0.20Quarterly | 2025年8月21日 | 2025年9月4日 |
除息 2026年11月19日
US$0.25
Quarterly
2026年11月19日登記 · 支付日 2026年12月3日
除息 2026年8月20日
US$0.25
Quarterly
2026年8月20日登記 · 支付日 2026年9月3日
除息 2026年5月21日
US$0.25
Quarterly
2026年5月21日登記 · 支付日 2026年6月4日
除息 2026年3月12日
US$0.25
Quarterly
2026年3月12日登記 · 支付日 2026年3月26日
除息 2025年11月20日
US$0.20
Quarterly
2025年11月20日登記 · 支付日 2025年12月4日
除息 2025年8月21日
US$0.20
Quarterly
2025年8月21日登記 · 支付日 2025年9月4日
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR9430.9萬0.10%987億 USD0.06%US$131.25-2.53%
First Trust SMID Cap Rising Dividend Achievers ETFSDVY7762.38萬0.73%106.56億 USD0.58%US$40.42-1.73%
Vanguard Morningstar Total Stock Market ETFVTI4460萬0.00%6893億 USD0.03%US$340.02-3.52%
iShares Russell 2000 ETFIWM4284.66萬0.06%715.37億 USD0.19%US$256.61-2.88%
Vanguard Extended Market ETFVXF1968.53萬0.02%302億 USD0.05%US$211.44-3.21%
iShares Russell 2000 Growth ETFIWO1538.61萬0.12%127.32億 USD0.24%US$320.43-3.57%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1444.84萬0.09%152.94億 USD0.03%US$50.99-2.58%
iShares S&P Small-Cap 600 Growth ETFIJT1408.15萬0.20%69.04億 USD0.18%US$153.65-2.69%
iShares Core S&P Small-Cap ETFIJR
First Trust SMID Cap Rising Dividend Achievers ETFSDVY
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
iShares S&P Small-Cap 600 Growth ETFIJTAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。